Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

NCT00957372 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

NCT01162460 ·Status: COMPLETED ·Phase: PHASE3

Anti-epileptogenic Effects of Eslicarbazepine Acetate

NCT06597084 ·Status: COMPLETED ·Phase: PHASE2

Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures

NCT01527513 ·Status: COMPLETED ·Phase: PHASE2

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

NCT01830400 ·Status: COMPLETED

Eslicarbazepine Acetate Monotherapy Long Term Study

NCT00910247 ·Status: COMPLETED ·Phase: PHASE3

Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers

NCT02777671 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

NCT01147003 ·Status: COMPLETED ·Phase: PHASE2

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

NCT00143143 ·Status: COMPLETED ·Phase: PHASE3

Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate

NCT02288312 ·Status: COMPLETED ·Phase: PHASE1

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

NCT03108729 ·Status: WITHDRAWN ·Phase: PHASE3

Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures

NCT02484001 ·Status: COMPLETED ·Phase: PHASE3

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.

NCT02283801 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

NCT01832038 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

NCT00988429 ·Status: COMPLETED ·Phase: PHASE3

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059 ·Status: COMPLETED ·Phase: PHASE3

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

NCT01227902 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

NCT00275925 ·Status: COMPLETED ·Phase: PHASE4

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

NCT01532726 ·Status: COMPLETED

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

NCT01261325 ·Status: COMPLETED ·Phase: PHASE3

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

NCT00988156 ·Status: COMPLETED ·Phase: PHASE3

Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures

NCT00692003 ·Status: TERMINATED ·Phase: PHASE3

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

NCT00425282 ·Status: COMPLETED ·Phase: PHASE3